Skip to main content
MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED logo

MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED — Investor Relations & Filings

Ticker · MVP ISIN · AU000000MVP2 LEI · 9845007EAECAOD1U4493 ASX Manufacturing
Open in API
Filings indexed 908 across all filing types
Latest filing 2015-09-29 Major Shareholding Noti…
Country AU Australia
Listing ASX MVP

About MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED

https://medicaldev.com

Medical Developments International Limited specializes in the development and distribution of emergency pain relief and respiratory products. The company's flagship product is Penthrox, a handheld, self-administered inhaler providing rapid-onset, non-opioid analgesia using methoxyflurane. Penthrox is utilized globally by emergency medical services, hospitals, and for procedural pain in various clinical settings. Additionally, the company manufactures a range of respiratory medical devices, including anti-static spacers and asthma management tools designed to optimize medication delivery. The organization focuses on providing portable, effective solutions for acute pain management and respiratory care, catering to healthcare professionals and patients in emergency, surgical, and primary care environments.

Recent filings

Filing Released Lang Actions
Change in substantial holding 3 pages 91.7KB
Major Shareholding Notification Classification · 100% confidence The document is a Form 604 Notice of change of interests of substantial holder under the Corporations Act 2001. It details changes in voting power and shareholdings of a substantial shareholder, including dates, nature of changes, and relevant interests. This type of filing is a notification of changes in significant share ownership levels, which corresponds to the category Major Shareholding Notification (MRQ). The document is not a financial report, earnings release, or management report, but a regulatory disclosure of shareholding changes.
2015-09-29 English
Change of Director's Interest Notice 2 pages 219.7KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details changes in securities holdings by a director, including the number of shares disposed and held before and after the change. The document is a formal notification of a director's personal share transactions. It does not contain financial performance data, management discussion, or other report content. This matches the definition of 'Director's Dealing' filings, which report personal share transactions by company directors and executives (insider trades). The document length is 3480 characters, consistent with a brief notice rather than a full report. Therefore, the correct classification is DIRS.
2015-09-29 English
Change of Director's Interest Notice 2 pages 219.0KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act, which relate to disclosure of changes in directors' shareholdings. The content details a director's disposal of shares, including dates, number of shares, and consideration. There is no financial performance data, earnings information, or management discussion. The document is a formal notification of a director's personal share transaction (insider trade). Therefore, it fits the category 'Director's Dealing' (DIRS). The document length is 3392 characters, consistent with a notice rather than a full report.
2015-09-29 English
MVP receives AUD$10million upfront payment 2 pages 227.4KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated 28 September 2015, stating that Medical Developments International Limited (MVP) has received an upfront payment of AUD $10 million related to a licensing agreement. It includes statements from the CEO and Chairman about the company's financial position and future capital management considerations. The document is short (2180 characters) and does not contain any detailed financial statements, comprehensive financial data, or management discussion and analysis. It is an update on a financing event (receipt of payment) and mentions potential capital management options. This fits the category of a Capital/Financing Update rather than a full financial report or earnings release. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2015-09-27 English
Annual Report to shareholders 72 pages 2.7MB
Annual Report Classification · 100% confidence The document is titled 'Full-Year Report 2015 Financial Year Ended 30 June 2015' and contains detailed financial data, operational review, sales figures, profit and loss information, and strategic updates for the fiscal year ending June 30, 2015. It includes comprehensive financial performance metrics such as net profit after tax, sales growth percentages, earnings before interest and tax, cash flow improvements, and bank debt status. The presence of a Chairman's and CEO's report, detailed segment reviews, and extensive operational and commercial updates further confirm this is a full annual report. The document length is substantial (15,000 characters), indicating it is the report itself rather than an announcement or summary. There is no indication that this is merely a publication announcement or a certification. Therefore, the document fits the definition of an Annual Report (10-K).
2015-09-24 English
Notice of Annual General Meeting/Proxy Form 10 pages 603.0KB
AGM Information Classification · 100% confidence The document is a Notice of the Twelfth Annual General Meeting (AGM) for Medical Developments International Limited. It includes details about the date, time, and location of the AGM, the agenda items such as receiving and considering the Financial Report, Directors' Report, and Auditor's Report for the year ended 30 June 2015, adoption of the Remuneration Report, and election of directors. It also provides detailed instructions on voting procedures, proxy appointments, and relevant legal provisions under the Corporations Act. The document does not contain the actual financial statements or reports but is a formal notice to shareholders about the upcoming AGM and the business to be conducted there. Therefore, it fits the definition of AGM Information (AGM-R) which includes presentations and materials shared during the Annual General Meeting, specifically the notice and agenda for the meeting.
2015-09-24 English

Browse filings by year

24 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.